{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "RESVERLOGIX CORP", "longName": "Resverlogix Corp.", "messageBoardId": "finmb_3103092", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.0905, "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.638, "fiftyTwoWeekLow": 0.049, "fiftyTwoWeekHigh": 0.25, "earningsTimestamp": 1668114000, "earningsTimestampStart": 1668114000, "earningsTimestampEnd": 1668114000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.01, "sharesOutstanding": 267799008, "bookValue": -0.223, "fiftyDayAverage": 0.09798, "fiftyDayAverageChange": -0.007480003, "fiftyDayAverageChangePercent": -0.07634214, "twoHundredDayAverage": 0.103285, "twoHundredDayAverageChange": -0.012785003, "twoHundredDayAverageChangePercent": -0.12378373, "marketCap": 26945558, "priceToBook": -0.40582958, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "priceHint": 4, "regularMarketChange": 0.0, "regularMarketTime": 1683871215, "regularMarketDayHigh": 0.0905, "regularMarketDayRange": "0.0905 - 0.0905", "regularMarketDayLow": 0.0905, "regularMarketVolume": 10000, "regularMarketPreviousClose": 0.0905, "bid": 0.0865, "ask": 0.103, "bidSize": 2000, "askSize": 2000, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 0.0905, "averageDailyVolume3Month": 542, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.0415, "fiftyTwoWeekLowChangePercent": 0.8469388, "fiftyTwoWeekRange": "0.049 - 0.25", "fiftyTwoWeekHighChange": -0.1595, "firstTradeDateMilliseconds": 1323327600000, "symbol": "RFS.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "4820 Richard Road SW", "address2": "Suite 300", "city": "Calgary", "state": "AB", "zip": "T3E 6L1", "country": "Canada", "phone": "403-254-9252", "fax": "403-256-8495", "website": "https://www.resverlogix.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the commercialization of apabetalone for Covid-19 in the United States and Canada; and developing cardiovascular and pulmonary arterial hypertension indications. The company was founded in 2001 and is headquartered in Calgary, Canada.", "fullTimeEmployees": 19, "companyOfficers": [{"maxAge": 1, "name": "Mr. Donald J. McCaffrey", "title": "Co-Founder, Chairman, Pres, CEO & Sec.", "fiscalYear": 2021, "totalPay": {"raw": 377687, "fmt": "377.69k", "longFmt": "377,687"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Aaron Bradley Cann C.A., CPA, CA, CPA, CBV", "title": "Chief Financial Officer", "fiscalYear": 2021, "totalPay": {"raw": 210673, "fmt": "210.67k", "longFmt": "210,673"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ewelina  Kulikowski Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2021, "totalPay": {"raw": 186900, "fmt": "186.9k", "longFmt": "186,900"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jan O. Johansson M.D., Ph.D.", "title": "Sr. VP of Medical Affairs", "fiscalYear": 2021, "totalPay": {"raw": 224866, "fmt": "224.87k", "longFmt": "224,866"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Michael  Sweeney M.D.", "age": 61, "title": "Sr. VP of Clinical Devel.", "yearBorn": 1961, "fiscalYear": 2021, "totalPay": {"raw": 368500, "fmt": "368.5k", "longFmt": "368,500"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Sarah  Zapotichny", "title": "Director of Investor Relations & Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}